Current Status of New Drugs and Multidisciplinary Approaches in Patients With Carcinoma of the Esophagus

This publication has 16 references indexed in Scilit:

• Cancer statistics, 1996
  CA: A Cancer Journal for Clinicians, 1996
• Paclitaxel (Taxol)
  New England Journal of Medicine, 1995
• Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus
  JNCI Journal of the National Cancer Institute, 1994
• Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer
  World Journal of Surgery, 1992
• Bleomycin/cis-platin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus: A prospective randomized multicentre study: The second Scandinavian trial in esophageal cancer
  Radiotherapy and Oncology, 1992
• Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus
  New England Journal of Medicine, 1992
• Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial
  Radiotherapy and Oncology, 1992
• Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma
  International Journal of Radiation Oncology*Biology*Physics, 1991
• Results of surgical treatment in 6,123 cases of carcinoma of the esophagus and gastric cardia
  Journal of Surgical Oncology, 1989
• Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma
  Radiotherapy and Oncology, 1985